STOK · Company research
Stoke Therapeutics, Inc. Common Stock (STOK): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 24.37 | $1,708,543,122.6 | 1598539122.60 | 16.4933333333333333 | — | — | 183.2217825844504021 | 4.9444594298315425 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.